Preclinical CRO Market Share, Size, Growth, Opportunity and Forecast 2021-2026

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Preclinical CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global preclinical CRO market exhibited strong growth during 2015-2020. A preclinical contract research organization (CRO) is a support center that provides expertise in research and development (R&D). It ensures that a medication or therapeutic gadget is sheltered and successfully developed before being launched in the market. It offers services that assist in clearing a pharmaceutical item through animal testing and advancing it to the clinical phase. Moreover, it provides critical studies to researchers, restorative workforce, different industries and legislative contacts for assessing drug efficacy and safety in animal models and completing Investigational New Drug (IND) filing studies.

The emerging trend of outsourcing represents one of the key factors impelling the market growth. Apart from this, preclinical CROs offer end-to-end services, such as toxicology testing, which is also contributing to the market growth. Furthermore, the market has witnessed a significant change in the process of drug approval by the Food and Drug Administration (FDA). The process now subjects the drug candidate to preclinical studies for establishing its safety and effectivity among humans before the approval. Besides this, the 21st Century Cures Act was passed by the United States Congress in 2016 to accelerate medical product development and fasten the approval process for the launch of medical devices and drugs. These initiatives are positively influencing the demand for preclinical CRO services. Other major factors, including the readily available skilled human resources, low cost of devices, and the increasing prevalence of chronic diseases, are anticipated to fuel the growth of the market. Looking forward, IMARC Group expects the global preclinical CRO market to grow at a CAGR of around 8% during the forecast period (2021-2026).

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global preclinical CRO market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, service and end use.

Breakup by Service:

Bioanalysis and DMPK Studies
Toxicology Testing
Others

Breakup by End Use:

Biopharmaceutical Companies
Government and Academic Institutes
Medical Device Companies

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Charles River Laboratories Inc., Covance Inc. (Laboratory Corporation of America Holdings), Eurofins Scientific, ICON Plc, MD Biosciences Inc. (MLM Medical Labs), Medpace, Parexel International Corporation, PPD Inc. and Wuxi AppTec.

Key Questions Answered in This Report:

How has the global preclinical CRO market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global preclinical CRO market?
What are the key regional markets?
What is the breakup of the market based on the service?
What is the breakup of the market based on the end use?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global preclinical CRO market and who are the key players?
What is the degree of competition in the industry?